Cited by 63Cell death mechanisms and regulationNeuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record.

CD95–CD95L: can the brain learn from the immune system?

Abstract

Members of the tumor necrosis factor/nerve growth factor receptor superfamily of cell-surface molecules can play the dual role of mediating either cytotoxicity or cell survival, both in the immune system and in the nervous system. A member of this superfamily, CD95 (also known as ApoI or Fas), was initially identified in the immune system and has been shown to mediate receptor-dependent programmed cell death and to be expressed in the nervous system. In neurodegenerative disorders, CD95-CD95 ligand expression on glial cells might precede receptor-mediated apoptosis by cells of the CNS. It is now being recognized that CD95 signaling by immune cells mediates effects other than apoptosis, such as cell survival and under inflammatory conditions expression of this protein promotes neural-immune interactions. Both neuroscientists and immunologists can contribute to defining the mechanisms underlying these divergent effects and utilize such knowledge to aid understanding of cell death and survival.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0166-2236(97)01180-6

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • FASLG induces cell death by binding to its receptor FAS, leading to caspase-dependent apoptosis.

    “FASLG induces cell death by binding to its receptor, FAS, leading to caspase-dependant apoptosis [16, 17].”

    From MicroRNA‐21 protects neurons from ischemic death (2010) · cites this paper as [16]

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 35

  1. Akbar, 1996, Eur. J. Immunol., 26, 294, 10.1002/eji.1830260204 · DOI
  2. Abbas, 1996, Cell, 84, 655, 10.1016/S0092-8674(00)81042-9 · DOI
  3. Nagata, 1997, Cell, 88, 355, 10.1016/S0092-8674(00)81874-7 · DOI
  4. Kaplan, 1994, J. Neurobiol., 25, 1404, 10.1002/neu.480251108 · DOI
  5. Dragunow, 1995, Brain Res. Rev., 21, 1, 10.1016/0165-0173(95)00003-L · DOI
  6. Ham, 1995, Neuron, 14, 927, 10.1016/0896-6273(95)90331-3 · DOI
  7. Frade, 1996, Nature, 383, 166, 10.1038/383166a0 · DOI
  8. Majdan, 1997, J. Neurosci., 17, 6988, 10.1523/JNEUROSCI.17-18-06988.1997 · DOI
  9. Mangan, 1991, J. Immunol., 146, 1541, 10.4049/jimmunol.146.5.1541 · DOI
  10. Bruce, 1996, Nature Med., 2, 788, 10.1038/nm0796-788 · DOI
  11. Liu, 1996, Cell, 87, 565, 10.1016/S0092-8674(00)81375-6 · DOI · Paper page
  12. Kayagaki, 1995, J. Exp. Med., 182, 1777, 10.1084/jem.182.6.1777 · DOI
  13. Muzio, 1996, Cell, 85, 817, 10.1016/S0092-8674(00)81266-0 · DOI · Paper page
  14. Schwartz, 1996, Trends Neurosci., 19, 555, 10.1016/S0166-2236(96)10067-9 · DOI
  15. Hsu, 1996, Cell, 84, 299, 10.1016/S0092-8674(00)80984-8 · DOI
  16. Natoli, 1997, Science, 275, 200, 10.1126/science.275.5297.200 · DOI
  17. Castro, 1996, Immunity, 5, 617, 10.1016/S1074-7613(00)80275-7 · DOI
  18. Park, 1996, Immunity, 4, 583, 10.1016/S1074-7613(00)80484-7 · DOI
  19. Piazza, 1997, J. Immunol., 158, 1503, 10.4049/jimmunol.158.4.1503 · DOI
  20. Nagata, 1995, Immunol. Today, 16, 39, 10.1016/0167-5699(95)80069-7 · DOI
  21. Dowling, 1996, J. Exp. Med., 184, 1513, 10.1084/jem.184.4.1513 · DOI
  22. D'Souza, 1996, J. Exp. Med., 184, 2361, 10.1084/jem.184.6.2361 · DOI
  23. Becher, B. et al. Neuroscience (in press)
  24. Nishimura, 1995, Brain Res., 695, 137, 10.1016/0006-8993(95)00699-Q · DOI
  25. Mogi, 1996, Neurosci. Lett., 220, 195, 10.1016/S0304-3940(96)13257-2 · DOI
  26. Alderson, 1994, Int. Immunol., 6, 1799, 10.1093/intimm/6.11.1799 · DOI
  27. Foote, 1996, J. Immunol., 157, 2749, 10.4049/jimmunol.157.7.2749 · DOI
  28. Cheng, 1994, Science, 263, 1759, 10.1126/science.7510905 · DOI
  29. Papoff, 1996, J. Immunol., 156, 4622, 10.4049/jimmunol.156.12.4622 · DOI
  30. Irmler, 1997, Nature, 388, 190, 10.1038/40657 · DOI
  31. Sato, 1995, Science, 268, 411, 10.1126/science.7536343 · DOI
  32. Ponton, 1996, J. Biol. Chem., 271, 8991, 10.1074/jbc.271.15.8991 · DOI
  33. Griffith, 1996, Immunity, 5, 7, 10.1016/S1074-7613(00)80305-2 · DOI · Paper page
  34. Hahne, 1996, Science, 274, 1363, 10.1126/science.274.5291.1363 · DOI
  35. Saas, 1997, J. Clin. Invest., 99, 1173, 10.1172/JCI119273 · DOI

Cited by

Sorted by citations

Metadata

Authors
Becher, B., Owens, T., Antel, J. P., & Barker, P. A.
Affiliations
Montreal Neurological Institute and Hospital (CA)
Venue
Trends in Neurosciences
Publisher
Elsevier BV
Published
1998-03
Volume
21
Issue
3
Pages
114-116
ISSN
0166-2236 (ISSN-L)
OpenAlex
W2043639971
Cited by
63
References
0
Citations by year
2023: 1 · 2016: 1 · 2015: 1
FWCI
0.80
Type
journal article
Language
en
Open access
closed
Locations
  • Trends in Neurosciences (publishedVersion)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Fas, Fas ligand, TNF receptor superfamily, apoptosis, cell survival, neurodegenerative diseases, glial cells, neuroimmune interactions, neuroinflammation, programmed cell death
MeSH terms
Brain, Humans, Immune System, Ligands, Apoptosis, fas Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review